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Abstract
Background: Retained placenta is associated with severe postpartum hemorrhage. Its etiology is unknown and its
biochemistry has not been studied. We aimed to assess whether levels of the antioxidative enzyme Glutathione
Peroxidase 1 (GPX1) and the transcription factor Nuclear Factor κβ (NFκβ), as markers of oxidative stress and
inflammation, were affected in retained placentas compared to spontaneously released placentas from otherwise
normal full term pregnancies.
Methods: In a pilot study we assessed concentrations of GPX1 by ELISA and gene (mRNA) expression of GPX1,
NFκβ and its inhibitor Iκβα, by quantitative real-time-PCR in periumbilical and peripheral samples from retained
(n = 29) and non-retained (n = 31) placental tissue.
Results: Median periumbilical GPX1 concentrations were 13.32 ng/ml in retained placentas and 17.96 ng/ml in non-
retained placentas (p = 0.22), peripheral concentrations were 13.27 ng/ml and 19.09 ng/ml (p = 0.08). Retained placental
tissue was more likely to have a low GPX1 protein concentration (OR 3.82, p = 0.02 for periumbilical and OR 3.95, p = 0.
02 for peripheral samples). Median periumbilical GPX1 gene expressions were 1.13 for retained placentas and 0.88 for
non-retained placentas (p = 0.08), peripheral expression was 1.32 and 1.18 (p = 0.46). Gene expressions of NFκβ and
Iκβα were not significantly different between retained and non-retained placental tissue.
Conclusions: Women with retained placenta were more likely to have a low level of GPX1 protein concentration in
placental tissue compared to women without retained placenta and retained placental tissue showed a tendency of
lower median concentrations of GPX1 protein expression. This may indicate decreased antioxidative capacity as a
component in this disorder but requires a larger sample to corroborate results.
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Background
Excessive blood loss after delivery is globally the main cause
of maternal mortality [1]. Retained placenta may be one of
the main causes of death due to hemorrhage in low income
countries but its pathophysiology is largely unknown [2, 3].
Retained placenta is diagnosed if the placenta has
not detached within 30 min of delivery and occurs
after 2–3% of deliveries. Manual removal is usually re-
quired to achieve placental separation or in response
to excessive bleeding [4, 5]. Studies within veterinary
medicine have shown that oxidative stress and inflam-
mation is increased in the placenta of dairy cattle with
retained placenta [6]. The pattern of increased oxida-
tive stress and systemic inflammation is also seen in
human pregnancies complicated by recurrent miscar-
riages, preterm delivery, small for gestational age birth
and preeclampsia, disorders characterized by an initial
defective placentation [7–9]. Epidemiological studies
have indicated that retained placenta is associated with
these pregnancy disorders [10, 11]. Whether oxidative
stress and/or inflammation is part of a common
underlying pathological mechanism in both retained
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placenta and defective placentation disorders remains
to be investigated.
Glutathione peroxidase (GPX), a selenium-dependent
antioxidant enzyme, plays an essential role in cellular anti-
oxidative defence. GPX1 is the main cellular isoform of
the enzyme and is responsible for approximately 80% of
enzyme activity in placental tissue [12]. Several studies
have shown that GPX1 enzyme activity and/or mRNA
expression is decreased in cases of preeclampsia [13–15].
NFκB (nuclear factor kappa-light-chain-enhancer of
activated B cells) has been implicated both in the regula-
tion of oxidative stress levels and inflammatory response
in the placenta [16, 17]. GPX1 is upregulated by NFκB
in response to oxidative stress and there are indications
that NFκB gene loci are activated in preeclamptic placenta
[18, 19]. NFκB forms a complex with IκBα (nuclear factor
of kappa light polypeptide gene enhancer in B-cells inhibi-
tor, alpha) in its inactive state. Phosphorylation of IκBα
initiates its dissociation from NFκB which is thereby
activated.
To our knowledge, no aspect of the biochemistry of
retained placenta in humans has been studied before.
This was a pilot study, the aim of which was to assess
protein- and gene expression of GPX1 and NFκB, as po-
tential markers of oxidative stress and inflammation, in
retained placentas compared to spontaneously released
placentas from otherwise normal full term pregnancies.
We hypothesized that retained placental tissue would,
like preeclamptic placentas, show signs of decreased
antioxidative capacity and increased inflammation.
Methods
A cross-sectional study based on prospectively collected
placentas between February 2013 and September 2014 was
performed. The study group was recruited from a tertiary
level obstetric department with approximately 7500 deliver-
ies per year and a rate of placental retention of 2.6% [20].
The total study group consisted of 29 retained placentas
and 31 spontaneously released placentas. All placentas
came from live full term singleton births with no clinical
indications of preeclampsia, diabetes or fetal growth restric-
tion. Sixty-two women were initially recruited to the
study. Two cases of retained placenta were excluded
from the study group because of unrecognized diabetes
in the mother and clinically suspected placenta accreta
respectively.
Retained placenta was defined as the identification of an
adherent plane between the decidua and the endometrium
during manual removal of the placenta, thus excluding
cases where the placenta is trapped behind a closed cervix.
Within a few days of each retained placenta being
included in the study, a randomly selected delivery with
spontaneous release of placenta within 30 min of delivery
was selected from the in-patient list for inclusion in the
study.
Sample collection and storage characteristics
Two full thickness peripheral and periumbilical placental
biopsies were collected immediately after placental delivery
at standardized sampling sites 1–2 cm from the umbilical
insertion and 1–2 cm from the periphery respectively. Sam-
ples were frozen at −70 °C within 10 min of delivery. The
time duration from delivery of the placenta until the sam-
ples were frozen was recorded. Variables relating to repro-
ductive history and current delivery, and data relating to
the newborn, were recorded for each woman admitted to
the study.
The median time from delivery of the placenta till the
samples were frozen at −70 °C was 5 min 15 s for
retained placentas and 4 min 38 s for non-retained
placentas (p = 0.4).
RNA extraction
Total RNA was extracted from each placental sample using
Bullet Blender Homogenizer (Next advance Inc., USA) and
Aurum total RNA mini kit (Bio-Rad Laboratories Inc.,
USA). One hundred 100 milligrams of placental tissue was
placed in a 1.5 ml sterile screw cap tube (Axygen Scientific,
USA) with 100 μL of RNAse free Beads (Next Advance
Inc., USA) with 700 μL lysis buffer and β-Mercaptoethanol
(Bio-Rad Laboratories Inc., USA). Homogenization time in
the Bullet Blender (Next advance Inc., USA) was ten mi-
nutes at the highest speed. Tubes were then centrifuged in
an Eppendorf centrifuge, 5415 R at 13,000 rpm for 20 min
at 4 °C. The total RNA was extracted from the supernatant
according to the manufacturer’s instructions. Twice the
amount of recommended DNase1 was used to ascertain no
remaining cDNA. The quantity of total RNA was measured
using the Pico Drop spectrophotometer (PicoDrop LTD,
UK). Five micro litres of each RNA sample were analyzed
using 1% Agarose gel electrophoresis in TAE buffer and vi-
sualized using ethidium bromide staining.
Real-time quantitative reverse transcriptase polymerase
chain reaction analysis (qRT-PCR)
iTaq™ Universal SYBR® Green One-Step Kit (Bio-Rad
Laboratories Inc., USA) was used for both cDNA synthesis
and real-time PCR analysis of GPX1(1), NFκB and IκBα.
The sequences of specific primers used to measure the
gene expression of GPX1(1) and housekeeping gene, tyro-
sine 3-monooxygenase/tryptophan 5-monooxygenase acti-
vation protein zeta (YWHAZ), are shown in Table 1.
Prime PCR SYBR Green Assay: NF-κB and IκBα (Bio-Rad
Laboratories Inc., USA) were used as primers for real-
time PCR analysis of NF-κB and IκBα. The specific primer
sequences for NF-κB and IκBα were not divulged by the
manufacturer (Bio-Rad Laboratories Inc., USA).
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Ten μL of iTaq Universal SYBR green reaction mix was
mixed with 0.25 μL of iScript reverse transcriptase, 50
pmol of each primer (forward and reverse) and 132 ng of
total RNA. The volume was then raised to 20 μL with
RNAse free water. The cDNA synthesis and real-time
PCR were performed in the PCR system CFX Connect
(Bio-Rad Laboratories Inc., USA) according to the manu-
facturer’s instructions. The real-time PCR products were
visualized in 2% agarose gel electrophoresis and ethidium
bromide staining.
Each sample was analyzed in duplicates and the mean
value of each sample was used for quantification. The
formula of Livak and Schmittgen [21] was used for
quantification of samples and normalization was per-
formed using the housekeeping gene YWHAZ.
Enzyme Linked-Immunosorbent Assay (ELISA)
Sandwich enzyme linked-immunosorbent assay (ELISA)
was used for quantitative determination of the intracellu-
lar GPX1(1) protein in placental samples using the GPX1
human intracellular ELISA kit (Adipogen International
Inc., USA). All samples were analysed in duplicates and
the researcher was blinded to outcome group. One hun-
dred 100 milligrams of placental tissue was rinsed with 1X
PBS. The tissue was placed in an Eppendorf tube with
500 μl of ice-cold homogenization buffer containing
1xPBS pH 7.2, supplemented with a protease inhibitor
(complete EDTA-free protease inhibitor cocktail, Roche,
Germany), 0.05 Sodium Azide and 0.5% Triton-X-100.
The tissue was sonicated on ice for 3 × 10 s (Branson
Sonifier 150, USA). The homogenate was incubated for
30 min at 4 °C and centrifuged at 12,000 × g for 15 min at
4 °C in an Eppendorf microcentrifuge. The supernatant
was assayed for total protein content using DC Protein
assay kit (Bio-Rad Laboratories Inc., USA), according to
the manufacturer’s instructions. One hundred microliters
of the supernatant was loaded to a polyclonal GPX1(1)
antibody-specific coated well of the ELISA plate. Each 100
μl from each sample contained an equal amount of total
protein. The ELISA procedure was performed according
to the manufacturer’s instructions (Adipogen International
Inc., USA). A standard curve was performed. GPX1(1) pro-
tein standard dilutions were between 4 and 0 nanogram
per millilitre. The absorbance was measured at 450 nm
using Ascent software v. 2.6. (Thermo Labsystems,
Finland).
Statistical analysis
Medians and interquartile range for non-normally dis-
tributed data were calculated groupwise for each marker
studied. Comparisons between groups were performed
using the Mann-Whitney U-test. Categorization into
high and low GPX concentration categories was deter-
mined based on optimal sensitivity to specificity cut-off
in an ROC curve. Odds ratios were calculated using
unconditional regression analysis. Correlations were ana-
lyzed using Spearman’s rank correlation coefficient. The
null hypothesis was rejected where p < 0.05. Study size
was planned to achieve an 80% probability of detecting a
30% difference in expression of GPX-1 protein between
retained placenta and non-retained placentas at 0.05 sig-
nificance level. Statistical analysis was carried out using
the PASW Statistics 18.0.0 (SPSS Inc., 233 South
Wacker Drive, 11th Floor Chicago, IL, 60606-6412). The
dataset upon which the results if the study rely can be
viewed in Attachment 1.
Results
Clinical characteristics
There were no significant differences between women
with and without retained placenta in regards to age,
previous parity, history of previous miscarriages, abor-
tions or caesarean sections, use of assisted reproductive
therapy, gestational age, epidural use, induction of labor
and instrumental delivery (Table 2 and 3).
Median duration of labor augmentation was longer
in deliveries with retained placenta (4 h 23 min vs 2 h
07 min; p = 0.03) as was median duration of labor
(10 h 45 min vs 8 h 30 min; p = 0.13). Median blood
loss in cases of retained placenta was 1600 ml
compared to 400 ml in the group without retained pla-
centa (p < 0.001). There was no significant difference
in fetal birthweight or placental weight between deliv-
eries with and without retained placenta (Table 3).
NFκB and IκBα gene and GPX1 protein and gene
expression in retained and non-retained placenta
NFκB and IκBα mRNA and GPX1 protein and mRNA
were detected at all placental sampling sites. Periumbilical
and peripheral GPX1 median protein concentrations were
lower in retained placentas compared to non-retained
placentas (13.32 ng/ml vs 17.96 ng/ml in periumbilical
samples, p = 0.22 and 13.27 ng/ml vs 19.09 ng/ml in per-
ipheral samples, p = 0.07) but the difference was not
Table 1 Sequences of primers used to measure gene expression
of GPX 1(1) and YWHAZ in retained and non-retained placenta
and applicon sizes for GPX1(1), YWHAZ, NF-κB and IκBα mRNA
Gene Primer Applicon size
GPX1(1) F: 5′ TTCCCGTGCAACCAGTTT 3′ 63
R:5′AACGAAGAGATTCTGAATTCCCTC 3′
YWHAZ F:5′GCAATTACTGAGAGACAACTTGACA3′ 96
R: 5′ TGGAAGGCCGGTTAATTTT 3′
NFKB PrimePCR SYBR Green Assay: NFKBAa 76
NFKBIA PrimePCR SYBR Green Assay: NFKBIAa 64
aspecific primer sequence not divulged by manufacturer (Bio-Rad Laboratories
Inc., USA)
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statistically significant or only approached statistical sig-
nificance. Median periumbilical and peripheral GPX1 gene
expression were higher in retained placentas (1.13 vs 0.88
for periumbilical samples and 1.32 vs 1.18 for peripheral
samples) which approached statistical significance for
periumbilical sample (p = 0.08) but was statistically non-
significant in peripheral samples (p = 0.47). There was no
significant difference in median periumbilical or periph-
eral NFκB and IκBα gene expression between retained
and non-retained placentas. Median mRNA values for
NFκB, IκBα and GPX1 and median protein concentrations
for GPX1 with interquartile ranges in retained and non-
retained placentas are presented in Table 4.
Risk of retained placenta according to level of GPX1
protein concentration
Women with retained placenta were more likely to have
a low level of GPX1 protein concentration in placental
tissue compared to women without retained placenta
(OR 3.82, p = 0.02 for periumbilical samples and OR
3.95 p = 0.02 for peripheral samples.) This association
was strengthened when the analysis was adjusted for
Table 2 Background characteristics among women with and without retained placenta
Maternal Characteristics Non-retained Placenta (n = 31) Retained Placenta (n = 29) p-valuea
Age, median (IQR) 30 6 31 5 ns
Age ≥35, n (%) 4 12.9% 5 17.2% ns
Previous parity, n (%)
None 17 54.8% 23 79.3% ref
1 11 35.5% 5 17.2% ns
>/=2 3 9.7% 1 3.4% ns
Previous miscarriages, n (%)
None 27 87.1% 21 72.4% ref
1 2 6.5% 6 20.7% ns
≥ 2 2 6.4% 2 6.9% ns
Previous abortions, n (%)
None 23 74.2% 22 75.9% ref
1 or 2 5 16.1% 4 13.8% ns
≥ 2 3 9.7% 3 10.3% ns
Previous cesarean section, n (%) 1 3.2% 3 10.3% ns
Previous retained placenta, n (%) 2 6.5% 0 0 nc
Assisted reproductive therapy, n (%) 2 6.5% 1 3.4% ns
ans is p-value > 0.05, nc not computable
Table 3 Delivery-related characteristics among women with and without retained placenta
Delivery-related characteristics Non-retained placenta (n = 31) Retained Placenta (n = 29) p-valuea
Gestational age, median (IQR) 40 + 1 15 40 + 5 12 ns
Induction of laborb, n (%) 5 16.1% 6 20.7% ns
Epidural analgesia, n (%) 22 71% 22 75.9% ns
Labor augmentation duration, median (IQR) 2h7min 3h46min 4h23min 4h13min 0.03
Labor augmentation, n (%) 24 77.4% 22 75.9% ns
Instrumental vaginal delivery, n (%) 1 3.2% 5 17.2% ns
Labor duration, median (IQR) 8h30min 6h12min 10h45min 7h11min ns
Labor duration > 12 h, n (%) 7 23.2% 12 41.4% ns
Fetal weight in g, median (IQR) 3590 500 3627 770 ns
Placental weight in g, median (IQR) 482 102 445 137 ns
Blood loss in ml, n (%) 400 200 1550 1325 <0.001
Blood loss≥ 1000 ml, n (%) 1 3.2% 23 79.3% <0.001
ans is p-value > 0.05
ball women were induced with misoprostol
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duration of labor augmentation (aOR 7.00, p = 0.01 for per-
ipheral samples and aOR 3.54, p = 0.08 for periumbilical
samples).
Odds ratios for retained placenta according to GPX1
protein concentration level are presented in Table 5. The
frequency of retained and non-retained samples in each
quantile of GPX concentration is shown in Fig. 1.
Correlations between GPX1 protein concentration and
delivery-related variables
GPX1 periumbilical and peripheral levels did not signifi-
cantly correlate with duration of labor, duration of labor
augmentation or total blood loss. The correlation with dur-
ation of oxytocin was the strongest (r = 0.33, p = 0.12, for
peripheral GPX1 levels). Median duration until placental
delivery was 1 h 22 min for retained placentas and 08 min
13 s for spontaneously released placentas (p < 0.001). Dur-
ation until placental release did however not correlate with
peripheral or periumbilical GPX1 protein concentrations in
either group.
Discussion
Women with retained placenta were significantly more
likely to have a low level of GPX1 protein concentration in
placental tissue compared to women without retained pla-
centa. Retained placental tissue showed a tendency of lower
median concentrations of GPX1 protein concentration and
increased GPX1 gene expression although the differences
were not statistically significant. The pattern of decreased
expression of GPX1 protein and somewhat increased
expression of GPX1 mRNA was however consistent across
both peripheral and periumbilical samples of retained
placentas.
Although this study did not allow for differences in
GPX1 gene or protein levels to be stated with a sufficient
degree of confidence, the tendency of reduced antioxida-
tive capacity in retained placentas is interesting in the
similarity it bears to preeclampsia. Reduced GPX enzyme
activity has been noted in several studies of preeclamptic
placentas [13, 15, 22, 23]. One of these showed that GPX
mRNA was simultaneously reduced however no distinc-
tion was made between the different isoforms of GPX
[23]. Other studies where GPX mRNA was analyzed
found no significant difference between preeclamptic pla-
centas and controls [14, 24, 25]. Physiologically, GPX1
gene expression in human tissue is thought to be upregu-
lated in response to oxidative stress, in part through an
NFκB mediated pathway [12].
It has been suggested that the pattern of increased GPX
activity in preeclamptic placentas, in the absence of a con-
current downregulated gene expression, occurs as a result
of posttranslational regulation [25]. GPX1 is a selenium
dependent protein but selenium deficiency would be ex-
pected to affect GPX also at the transcriptional level [26]
Table 4 Median protein concentration or gene expression of GPX 1, NFκB and IκBα in retained and non-retained placenta
Non-retained placenta (n = 31) Retained placenta (n = 29) Median difference
p-valueMedian Interquartile Range Median Interquartile Range
GPX 1 concentration ng/ml
Periumbilical 17.96 (7.74–20.07) 13.32 (8.49–17.67) p = 0.22
Peripheral 19.09 (11.81–20.39) 13.27 (3.24–19.18) p = 0.07
GPX 1 mRNA expressiona
Periumbilical 0.88 (0.71–1.54) 1.13 (0.91–1.84) p = 0.08
Peripheral 1.18 (0.53–1.65) 1.32 (0.87–1.72) p = 0.47
IκBα mRNA expressiona
Periumbilical 0.95 (0.64–1.56) 1.14 (0.74–2.44) p = 0.16
Peripheral 0.99 (0.45–2.64) 1.96 (0.55–5.19) p = 0.25
NFκB mRNA expressiona
Periumbilical 0.99 (0.90–1.28) 1.02 (0.82–1.24) p = 0.71
Peripheral 1.04 (0.84–1.22) 1.22 (0.85–1.39) p = 0.17
arelative expression to YWHAZ housekeeping gene
Table 5 Level of GPX 1 protein concentration and risk of retained placenta
Risk of retained placenta
Unadjusted Odds Ratio p-value Adjusted Odds Ratiob p-value
Low valuea periumbilical GPX 1 3.82 0.02 3.54 0.08
Low valuea peripheral GPX 1 3.95 0.02 7.00 0.01
alow-value assessment based on sensitivity-specificity analysis of ROC curve. Periumbilical GPX 1 cut-off = 15.62 ng/ml, peripheral GPX 1 = 19.90 ng/ml
badjusted for duration in minutes of augmented labor
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Fig. 1 Frequency of samples in each quartile of GPX1 protein concentration for periumbilical and peripheral placental samples from retained and
non-retained placentas. * superimposed line showing hypothetical normal GPX1 response to labor
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There are however a number of protein to protein interac-
tions that could modulate GPX protein expression at the
posttranslational level [12] which could explain the pat-
tern of normal or possibly increased gene expression and
decreased protein expression in retained placentas that
our results tentatively suggest.
We found that low GXP 1 concentrations were signifi-
cantly more common in retained placental tissue. The
distribution of biochemical data is often skewed to the left
since there are more people with a low to normal value as
opposed to a high value which indicates illness. It may be
that GPX enzyme concentrations in normal human
placenta show the opposite pattern with high to normal
values being more common as a result of an adequate
physiological response to oxidative stress from preg-
nancy and labor. It has been suggested that preeclamp-
tic placentas demonstrate lower GPX activity because
of an impaired capacity to respond to oxidative stress
[14]. Likewise what we may be seeing in the group of
retained placentas is the absence of this response.
We adjusted for labor augmentation in a second regres-
sion analysis since labor augmentation is associated with
retained placenta [20] and has been shown to decrease the
GPX substrate glutathione (GSH) indicating increased oxi-
dative stress [27]. Duration of labor augmentation could
also act as a proxy variable for labor duration which has
also been shown to induce oxidative stress in the placenta
[28], although another study has suggested that increased
oxidative stress and upregulation of antioxidative defence
may be mainly localized to the fetal membranes [14].
It has been shown that a gradient of decreasing oxy-
genation exists across the placenta from periumbilical to
peripheral tissue [29] with the periphery more prone to
histological signs of underperfusion [30]. Although we
noted a trend of higher gene and protein expression in
peripheral samples of all markers studied, the difference
in median expression was not significant.
We found no significant differences between gene
expression of NFκβ and Iκβ alpha between retained and
non-retained placentas. The understanding of NFκβ as a
regulator of oxidative stress and inflammation is relatively
new [18]. Gene expression of NFκβ and Iκβ alpha has not
been studied in preeclamptic placenta to our knowledge.
It has however been shown that pro-inflammatory
processes in the placenta that occur in response to oxida-
tive stress in vitro are in large part mediated by NFκβ
pathways and it has therefore been suggested to play a role
in the pathophysiology of this disorder [16]. This study
did not suggest an upregulation of NFκβ in retained pla-
centa but the results alone are insufficient to preclude a
role for inflammation in the development of this disorder.
A closer analysis of inflammation in retained placenta
should also include “downstream” products of activated
inflammatory pathways such as tissue tumor necrosis
factor-alpha, placental interleukins, cyclooxygenase-2, and
markers of apoptosis as well as other triggers of inflamma-
tory response and endothelial dysfunction such as soluble
fms-like tyrosine kinase-1 (sFlt-1) [16, 31].
The main strength in the study is the homogeneity of
the study group. All samples, both retained and non-
retained, came from healthy full term pregnancies after
vaginal delivery which decreases the confounding effect
that differing incidence of other placental disorders, ges-
tational age and mode of delivery between groups would
have had on the outcomes studied. Samples were also
frozen within a short interval minimizing the effect of
exposure to air on oxidative stress levels in the placenta.
There was a large inter-sample variability in GPX1 pro-
tein concentrations and relative mRNA expression in our
study material which limited the precision of our results.
By definition our placentas were collected after labor, a
process that may influence levels of oxidative stress per se,
as discussed above, [14] but may arguably also increase
variability in measurements. Few, if any, other studies on
the biochemistry of retained placenta exist. This pilot
study is the first to test the hypothesis of increased oxida-
tive stress and inflammation in retained placenta and is
consequently limited in the scope of its analysis. Only
GPX1 out of at least 4 GPX subtypes relevant to the study
of the placenta was analyzed. A more substantial assess-
ment of oxidative stress in relation to retained placenta
would require analysis not only these other subtypes but
also other antioxidative enzymes as well as by-products of
oxidative stress in placental tissue. GPX1 is however the
main enzyme isoform in the placenta and is also a vital
antioxidative enzyme, as illustrated by the fatal effect of
severe oxidative stress on GPX1 knock-out mice [32]. We
assessed protein concentration of GPX1 but not enzyme
activity. Given that we only analysed GPX1 protein con-
centration, we chose not to assess enzyme activity as this
measurement does not distinguish between isoforms of
GPX which would make interpretation and correlation
analysis difficult. A further limitation is inherent to the
diagnosis itself and will be a constraint in all studies of
retained placenta. Retained placentas have by definition
been adherent to the uterine wall at least 30 min before
placental delivery and almost all cases receive full
anesthesia during manual removal of the placenta. We
can only speculate as to the effect that these factors have
on the levels of oxidative stress and inflammation in the
placenta. Our sensitivity analysis however showed no cor-
relation between duration till placental release and GPX1
protein levels.
If retained placenta has both epidemiological and bio-
chemical properties in common with preeclampsia this
might suggest that retained placenta is not a random oc-
currence but part of a spectrum of placental disorders
and that it is to some extent predictable. Further studies
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of the role of oxidative stress in retained placenta might
be instrumental in the prevention or less invasive treat-
ment of this disorder.
Conclusions
Women with retained placenta were more likely to have
a low level of GPX1 protein concentration in placental
tissue compared to women without retained placenta
and retained placental tissue showed a tendency of lower
median concentrations of GPX1 protein expression. The
results are statistically uncertain but, given the similarity
to patterns of decreased GPX activity seen in several
studies of preeclamptic placentas, may warrant further
investigation into the relation between retained placenta
and this disorder and a discussion of the role of oxida-
tive stress in the pathophysiology of retained placenta.
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